Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Some extracts from the Cohen Report

Point - Counterpoint. Respectfully we will continue to disagree. We can get to $5 and beyond without a R/S. A stock price is not only determined by current financial situation but forecasted financial situation, perception by investors, history of management, credibility, emotions, etc....

The number of outstanding shares is large but many companies have more shares outstanding. So either we have to generate a lot of income and or be in sectors where investors are willing to pay a much higher PE ratio because of the technology outlook. If we get in on the cutting edge of a number of growing technologies, with no debt, and a positive affirmation from the PTO, I believe we can sustain a pps well past $5.

RG can do this. We have technical expertise, we have incoming funds, we have the mmp. Let's get out patents confirmed, sign a boatload of licensees, apply for Nasdaq listing, acquire a few more companies, and reward RG handsomely. He will deserve to be a millionaire, maybe billionaire, if he can pull this off without R/S. The ingredients are there for the right chef to make a very rich desert for us all.

Share
New Message
Please login to post a reply